Pneumocystis jirovecii pneumonia in patients with lung cancer receiving immune checkpoint inhibitors: a retrospective nationwide population-based cohort study from South Korea

Abstract Background This study determined the incidence of Pneumocystis jirovecii pneumonia (PCP) in patients with lung cancer based on immune checkpoint inhibitor (ICI) exposure. Methods National claims data were obtained from 68,174 patients with lung cancer treated with ICIs or comparator non-ICI...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jiyun Jung, Seong Yeon Park, Hee Bum Jo, Jae Yoon Park, Dalyong Kim, Kyoungmin Lee, Sungim Choi
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Springer 2025-05-01
coleção:	Discover Oncology
Assuntos:	Immune checkpoint inhibitors Chemotherapy Pneumocystis jirovecii Pneumonia Immunomodulation
Acesso em linha:	https://doi.org/10.1007/s12672-025-02627-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!